Literature DB >> 1513586

Magnetic resonance imaging of orbital lymphangioma with and without gadolinium contrast enhancement.

J B Bond1, B G Haik, J L Taveras, B A Francis, Y Numaguchi, F Mihara, K L Gupta.   

Abstract

BACKGROUND: Lymphangioma is a vascular tumor of the orbit with a propensity for recurrent hemorrhage. These tumors may be difficult to diagnose in young patients who present with sudden proptosis due to hemorrhage into a previously unrecognized lesion. Magnetic resonance imaging (MRI) should be ideally suited for evaluating lymphangioma due to the unique ability of MRI to characterize hemorrhage because of the paramagnetic qualities of hemoglobin.
METHODS: The authors performed T1-, T2-, and proton density-weighted MRI on 12 patients with orbital lymphangioma. Six patients underwent MRI with gadolinium-DTPA contrast enhancement. The MRI studies were performed using a 1.5 Tesla super-conducting magnetic resonance unit, except for 3 early studies performed with a 0.5 Tesla unit. All studies were performed with orbital surface coil imaging. Computed tomography (CT) was performed in 10 patients.
RESULTS: Tumor was visible on MRI in all 12 patients. Magnetic resonance imaging delineated clearly the internal structure of subacute and chronic hemorrhagic cysts, and differentiated between these tumors because of the different paramagnetic qualities of subacute hemorrhage compared to chronic hemorrhage. In two patients, MRI detected large tumor feeding vessels by the flow void phenomenon unique to MRI. Computed tomography did not detect these vessels. Gadolinium-contrasted T1-weighted MRI did not further delineate or characterize the tumor.
CONCLUSION: Magnetic resonance imaging is the modality of choice for imaging orbital lymphangioma because of its unequalled differentiation of hemorrhagic cysts, and its unique ability to detect tumor feeding vessels by the flow void phenomenon.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1513586     DOI: 10.1016/s0161-6420(92)31809-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  5 in total

1.  Management of orbital lymphangioma using intralesional injection of OK-432.

Authors:  Y Suzuki; A Obana; Y Gohto; T Miki; H Otuka; Y Inoue
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Resection of an orbital lymphangioma with the aid of an intralesional liquid polymer.

Authors:  Amit D Malhotra; Mona Parikh; Daniel C Garibaldi; Shannath L Merbs; Neil R Miller; Kieran Murphy
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

3.  Clinico-epidemiological analysis of 1000 cases of orbital tumors.

Authors:  Hiroshi Goto; Naoyuki Yamakawa; Hiroyuki Komatsu; Masaki Asakage; Kinya Tsubota; Shun-Ichiro Ueda; Rei Nemoto; Kazuhiko Umazume; Yoshihiko Usui; Hideki Mori
Journal:  Jpn J Ophthalmol       Date:  2021-07-27       Impact factor: 2.447

4.  Spontaneous Retrobulbar Haematoma.

Authors:  Mehmet Deveer; Nesat Cullu; Halil Beydilli; Hamdi Sozen; Onder Yeniceri; Selcuk Parlak
Journal:  Case Rep Radiol       Date:  2015-05-10

5.  Orbital Lymphangioma: Characteristics and Treatment Outcomes of 12 Cases.

Authors:  Young Jun Woo; Chang Yeom Kim; Bradford Sgrignoli; Jin Sook Yoon
Journal:  Korean J Ophthalmol       Date:  2017-05-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.